Levosimendan in ECMO: A Paradigm Shift or an Adjunctive Option?
Levosimendan, a calcium-sensitizing inodilator, has emerged as a promising adjunctive therapy in patients undergoing veno-arterial extracorporeal membrane oxygenation (V-A ECMO). Its pharmacodynamic profile, combining positive inotropy with vasodilation and mitochondrial protective effects, offers a...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-12-01
|
| Schriftenreihe: | Future Pharmacology |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2673-9879/5/4/70 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|